Keyword: GlaxoSmithKline (GSK)


FDA Greenlights GSK’s MMR Vaccine

07.06.2022 -

The US Food and Drug Administration (FDA) has greenlit GSK’s Priorix-branded GSK’s mumps and rubella vaccine (MMR) for people 12 months and older. It is only the second...


Pfizer to Quit GSK Consumer JV with Cash Windfall

03.06.2022 -

Pfizer is set to start divesting its 32% stake in Haleon, the consumer health joint venture with GSK, when the British pharma completes the company’s spinoff and Haleon...


GSK Officially Changes Name – to GSK

18.05.2022 -

Major UK pharmaceutical producer GlaxoSmithKline is slimming down not only by spinning off its consumer health business. It is also shedding excess verbiage by trimming...


GSK Union Threatens Strike over “unacceptable” Pay Offer

25.04.2022 -

British drugs giant GlaxoSmithKline is facing what could be the first industrial action in its history. Some 86% of its employees organized in the trade union Unite at...


GSK to Buy Sierra Oncology for £1.5 Billion

14.04.2022 -

British drugs giant GlaxoSmithKline (GSK) is buying US cancer treatment developer Sierra Oncology for £1.5 billion in a deal observers see as designed to fend off...


Six Firms to Make Vaccines for German Emergency Supply

12.04.2022 -

Germany’s economics ministry has budgeted up to €2.9 billion ($3.14 billion) to ensure sufficient supply of mostly mRNA-based Covid-19 vaccines to be able to deal with...


CDC and FDA Sideline Last Covid Antibody Treatment

07.04.2022 -

The US Centers for Disease Control and the Food and Drug Administration have removed the IV antibody treatment sotrovimab made by GlaxoSmithKline (GSK) and Vir...


WHO Rejects Medicago's Covid Vaccine

29.03.2022 -

The Covid-19 vaccine Covifenz made by Canada’s Medicago, approved for use in the country in February, has been rejected for review by the World Health Organization (WHO)...